[ad_1]
The spokesperson added that "Results further strengthen the body of evidence for vaccine safety and immunity"As reported by a newspaper "The Guardian" British Tuesday.
AstraZeneca did not provide full details about the vaccine and when the results of the third phase of the vaccine-related clinical trials will be released, which will show whether the vaccine is working well enough before it is more widely adopted.
The Oxford vaccine is expected to be the first of its kind developed by major pharmaceutical companies to gain regulatory approval, alongside another vaccine from Bevaser and Biotec.
The news that the elderly get an immune response from the vaccine is positive, because the immune system weakens with age and the elderly are at higher risk of dying from the virus.
If successful, the vaccine will allow the world to return to a certain normalcy after the pandemic.
“>
British pharmaceutical company AstraZeneca, which helps make the vaccine, said Monday that the vaccine developed by Oxford University also elicits fewer negative responses among the elderly.
The successful vaccine is seen as a game changer in the battle against the Coronavirus, which has killed more than 1.15 million people, shut down sectors of the global economy and changed the normal lives of billions of people.
A spokesperson for AstraZeneca said: “It is encouraging to see that immune responses were similar among the elderly and the young, and that the reaction was lower in the elderly, where the severity of Covid-19 disease is greatest.”
The spokesman added that “the results increase the construction of a set of tests of the safety and immunity of the vaccine”, according to the British newspaper “The Guardian”, this Tuesday.
AstraZeneca did not provide full details about the vaccine and when the results of the third phase of the vaccine-related clinical trials will be released, which will show whether the vaccine is working well enough before it is more widely adopted.
The Oxford vaccine is expected to be the first of its kind developed by major pharmaceutical companies to gain regulatory approval, along with another vaccine from Bevizer and Biotec.
The news that the elderly get an immune response from the vaccine is positive, because the immune system weakens with age and the elderly are at higher risk of dying from the virus.
If successful, the vaccine would allow the world to return to a certain normality after the pandemic.
[ad_2]
